Limiting Antipsychotic Medications Shows Long-Term Benefits

The renewed debate surrounding the risk/benefit ratio of using antipsychotic medications for new onset psychotic illness has challenged the traditional recommendation of continued medication treatment for at least one year after remission.  While previous studies have documented an increased rates of relapse among those whose medications are discontinued, this risk is weighed against the potential […]

Tags: , ,